1. Update on the role of extracellular vesicles in rheumatoid arthritis
   Hai-bing Miao et al, 2022, Expert Reviews in Molecular Medicine CrossRef
2. miRNA-Mediated Epigenetic Regulation of Treatment Response in RA Patients—A Systematic Review
   Arkaitz Mucientes et al, 2022, International Journal of Molecular Sciences CrossRef
3. Fibroblast pathology in inflammatory joint disease
   Lucy‐Jayne Marsh et al, 2021, Immunological Reviews CrossRef
4. Overexpression of long noncoding RNA LINC00638 inhibits inflammation and oxidative stress in rheumatoid arthritis fibroblast‐like synoviocytes by regulating the Nrf2/HO‐1 pathway
   Yanqiu Sun et al, 2022, Immunity, Inflammation and Disease CrossRef
5. LncRNA FLVCR1-AS1 mediates miR-23a-5p/SLC7A11 axis to promote malignant behavior of cervical cancer cells
   Xi Zhou et al, 2022, Bioengineered CrossRef
6. In vitro and in vivo metabolic profiling of PD105, a PI3Kδ inhibitor, using UHPLC-Q-Exactive plus-MS
   Panhong Wei et al, 2023, Xenobiotica CrossRef
7. MicroRNAs (miRNAs) in Cardiovascular Complications of Rheumatoid Arthritis (RA): What Is New?
   Daniela Maria Tanase et al, 2022, International Journal of Molecular Sciences CrossRef
8. Immune Modulation Using Extracellular Vesicles Encapsulated with MicroRNAs as Novel Drug Delivery Systems
   Yasunari Matsuzaka et al, 2022, International Journal of Molecular Sciences CrossRef
9. MicroRNA-Mediated Epigenetic Regulation of Rheumatoid Arthritis Susceptibility and Pathogenesis
   Cen Chang et al, 2022, Frontiers in Immunology CrossRef
10. MicroRNA-345-3p is a potential biomarker and ameliorates rheumatoid arthritis by reducing the release of proinflammatory cytokines
    Jun Ma et al, 2023, Journal of Orthopaedic Surgery and Research CrossRef
11. Non-coding RNAs involved in fibroblast-like synoviocyte functioning in arthritis rheumatoid: From pathogenesis to therapy
    Yuwei Peng et al, 2024, Cytokine CrossRef